Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...
Notably, GSK said it recently reduced the list price of Advair HFA by an average ... of those products and the rest of its ...
AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...
Qualcomm and its rival Propeller are emerging as the tech companies to partner with in the development of smart inhalers. Virtually all the companies active in the asthma and COPD markets have ...
Efforts to reduce the disproportionate morbidity of Black and Latinx patients with COPD have been mostly unsuccessful ... reliever-triggered inhaled glucocorticoid strategy plus usual care or to ...
Addressing a workshop titled "Phasing out CFC in Metered Dose Inhalers", Mr Singh said, "Environment-friendly asthma and COPD (Chronic Obstructive Pulmonary Diseases) inhalers are being introduced ...
.In December 2024:- AstraZeneca- A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect ...
Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback